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ABSTRACT 
The effects of chronic liver insufficiency resulting from end-to-side portacaval anastomosis (PCA) on glutamine 
synthetase (GS) activities, protein and gene expression were studied in brain, liver and skeletal muscle of male adult 
rats. Four weeks following PCA, activities of GS in cerebral cortex and cerebellum were reduced by 32% and 37% 
(p<0.05) respectively whereas GS activities in muscle were increased by 52% (p<0.05). GS activities in liver were 
decreased by up to 90% (p<0.01), a finding which undoubtedly reflects the loss of GS-rich perivenous hepatocytes 
following portal-systemic shunting. Immunoblotting techniques revealed no change in GS protein content of brain 
regions or muscle but a significant loss in liver of PCA rats. GS mRNA determined by semi-quantitative RT-PCR was 
also significantly decreased in the livers of PCA rats compared to sham-operated controls. These findings demonstrate 
that PCA results in a loss of GS gene expression in the liver and that brain does not show a compensatory induction of 
enzyme activity, rendering it particularly sensitive to increases in ammonia in chronic liver failure. The finding of a 
post-translational increase of GS in muscle following portacaval shunting suggests that, in chronic liver failure, muscle 
becomes the major organ responsible for the removal of excess blood-borne ammonia. 
Keywords: glutamine synthetase; gene expression; portacaval anastomosis; hepatic encephalopathy; liver; skeletal muscle; 
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INTRODUCTION 
Glutamine synthetase (GS) (EC 6.3.1.2) is responsible for the ATP-dependent amidation of glutamate to glutamine. In 
liver and in brain, GS is compartmentalized. In the case of liver, GS activities are expressed by a small population of 
perivenous hepatocytes (Gerbhardt and Mecke, 1983), in brain, GS is localized almost exclusively to astrocytes 
(Norenberg and Martinez-Hernandez, 1979).  
There is a convincing body of evidence to suggest that ammonia toxicity is the major factor in the pathogenesis of 
hepatic encephalopathy (HE) (Butterworth et al., 1987). Unlike liver, brain and skeletal muscle rely almost exclusively 
on glutamine formation for the effective removal of excess ammonia (Cooper et al., 1985). In liver failure, it has been 
suggested that muscle glutamine synthesis becomes an important alternative pathway for removal of blood-borne 
ammonia via GS (Ganda and Ruderman, 1976). 
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In order to further elucidate the molecular basis for the tissue-selective changes in capacity for ammonia removal in 
chronic liver failure, the present study was undertaken to assess the effects of portacaval anastomosis (PCA) in the rat 
on GS protein and gene expression in brain, liver and skeletal muscle. 
MATERIALS AND METHODS 
Animal Surgery  
Adult male Sprague-Dawley rats weighing 175-200 g were anesthetized with halothane and an end-to-side PCA was 
performed essentially according to the procedure of Lee and Fisher (1961). Rats underwent a laparotomy, the inferior 
vena cava and portal vein were isolated, the inferior vena cava partially clamped (anastomosis clamp, Roboz 
Instruments Inc., Washington, D.C.), and an elliptical piece of vein, 1.5 times the portal vein diameter was removed. 
The portal vein was ligated, cut, and an end-to-side anastomosis performed under a dissecting microscope. Total 
surgery time was <15 min. Sham-operated control rats, matched for weight, were similarly anesthetized, a 
laparotomy was performed, and the inferior vena cava and portal vein were occluded for 15min. 
Following surgery, animals were housed individually under constant conditions of temperature, humidity, and light 
cycles and were allowed free access to standard laboratory chow (except for sham operated pair-fed rats) and water. 
The animals were cared for in accordance with the principles of the Guide to the Care and Use of Experimental 
Animals, Vol. 1 (1980) and Vol. 2 (1984) (Canadian Council of Animal Care, CCAC, Ottawa, Canada). Overall mortality 
for shunted rats was less than 10%. 
Tissue Sampling  
Groups of rats were sacrificed by decapitation 4 weeks following PCA or sham operation. Brains were rapidly 
removed on ice and, at the same time, livers and a 1 g sample of vastus lateralis muscle were rapidly removed and 
immediately frozen. All tissues were stored at -70°C until use. 
Blood ammonia was measured in neck blood according to the method of Kun and Kearney (1974) 
GS Activities  
Glutamine synthetase (EC6.3.1.2) was measured in tissue homogenates using a modification of the procedures 
described by Patel et al. (1983) and Lavoie et al. (1987). The assay mixture contained in a final volume of 0.1 ml: 
imidazole buffer 100 mM, pH 7.2;12.5 mM MgCl2; 20 mM mercaptoethanol; 10 mM ATP; 4 mM ammonium chloride; 13 
mM phosphoenolpyruvate; 50 units of pyruvate kinase; 0.16% (v/v) Triton X-100; and 0.6 mg, 0.6 mg and 2.4 mg of brain, 
liver and skeletal muscle homogenates respectively. Homogenization was made by Teflon pestle in various buffers 
depending on the tissue: imidazole buffer 100 mM, pH 7.2 for brain; Tris HC1 50 mM-EDTA for liver and skeletal muscle. 
Following preincubation, 30 min at 37°C, [l-14C]glutamate (specific activity 60 mCi/mmol, New England nuclear) was added 
to provide a final concentration of 20 mM for brain tissue, 50 mM for liver, and 60 mM for skeletal muscle. Optimal substrate 
concentrations were derived from a separate series of experiments in tissue homogenates. Boiled homogenates served as 
blanks in all cases. After incubation at 37°C for 60 min for brain (30 min for liver and muscle) the reaction was stopped by 
adding 1 ml ice-cold water and the mixture was immediately applied to 3 cm x 0.7 cm columns containing anion exchange 
resin (Dowex AG 1 x 8, acetate form). Columns were made from 2.5 ml plastic pipet tips (Walter Sarstedt, Princeton, New 
Jersey) equilibrated by eight successive washings with distilled water. Experiments with standard mixtures of 
[14C]glutamate and [14C]glutamine showed that, following elution with 5 ml cold (4°C) distilled water, [l4C]glutamate was 
quantitativelyretained on the ion-exchange column. Protein content of homogenates was determined by the methods of 
Lowry et al. (1951). Enzyme activities were expressed as micromoles of glutamine formed per hour per milligram of 
protein. 
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Immunoblotting 
 
Tissues were homogenized in RIPA buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.1% SDS, 1% Triton X-100,0.5% 
sodium deoxycholate), and a protease inhibitor mixture consisting of 1mM EDTA, 0.1 uM pepstatin A, 1 ug/ml 
leupeptin, 1 ug/ml aprotinin, and 100 ug/ml phenylmethyl-sulfonyl fluoride. After centrifugation at 12,000 g for 15 
min, protein extracts (50 ug) were boiled for 10 min in loading buffer (50 mM Tris-HCl, pH 6.8, 10% glycerol; 2% SDS, 
0.1 M dithiothreitol, 0.1% bromophenol blue). Proteins were resolved by 8% denaturing SDS-polyacrylamide gels and 
transferred overnight to nitrocellulose filters. The membranes were blocked for 2 h in Tris-buffered saline (TBS) 
containing 5% dry milk and 0.1% Tween 20, then incubated for 1 h with a mouse monoclonal antibody directed 
against rat GS (Transduction laboratories, Lexington, KY). The blots were subsequently probed with anti-mouse 
horseradish peroxidase-conjugated antiserum (Promega, Madison, Wl) diluted 1/40,000 in the same buffer. After 
extensive washing with TBS, the peroxidase activity was detected by cheminulescence using the ECL detection system 
(Amersham, Arlington Heights, IL). 
RNA Extraction 
 
Total RNA was extracted using TRI Reagent (MRC Inc., Ohio) according to the manufacturer's protocol. Putative 
contaminating DNA was eliminated by adding 100 U of RNase-free DNase I per 50u g of total RNA at 37°C for 1 h. 
Purified RNA was then extracted with phenol, precipitated with ethanol and resuspended in diethylpyrocarbonate-
treated water. RNA samples were kept at -70°C until use. 
RT-PCR Analysis 
 
Glutamine synthetase expression was investigated by the reverse transcription-polymerase chain reaction (RT-PCR) 
B-Actin was used as an internal standard to monitor loading variations. Total RNA (0.5 ug) was mixed with 10 mM 
Tris-HCl2 (pH 8.3), 1.0 mM MgCl2, 50 mM KC1, 0.01%(w/v) bovine serum albumin, 100 uM dNTPs, primers at 1 uM 
each, AMV reverse transcriptase (80 U/ml), Taq DNA polymerase (20 U/ml) and 50 uCi/ml [a32P]dCTP (3000 
Ci/mmol), for a total reaction volume of 50 ul. The reactions were initially heated at 50°C for 15 min followed by PCR 
at 95°C for 30 sec, 59°C for 45 sec and 72 C for 1 min. Amplification efficiency conditions were determined after a 
kinetic study, to ensure all experiments were performed within the exponential phase of amplification where PCR 
product remains proportional to initial template concentration (data not shown). B-Actin and GS mRNAs were 
amplified for 24 cycles. After amplification, the samples were electrophoresed onto 8% polyacrylamide gels, dried, 
autoradiographed at -70°C with an intensifying screen. Each band was excised and Cerenkov radiation was 
quantitated using a B-counter. Oligonucleotide primers were designed using the PRIME program (Genetic Computer 
Group, Wisconsin) and synthesized by the Sheldon Biotechnology Center (McGill University, Quebec) based on the 
following GeneBank accession numbers: X00351 (B-Actin, Ponte et al, 1984), and M91652 (GS, Mill et al, 1991). The 
forward and reverse primer sequences were as follows: CATCCCCCAAAGTTCTAC and CCAAAGCCTTCATACATC (B-
Actin, 347bp); ACCTGACAAATGGCCCTAC and ACCAAAAAATAACCCCCC (GS, 482bp). The specificity of the 
oligonucleotide primers was verified using the program BLASTN (National Center for Biotechnology Information, 
Bethesda, MD). 
Statistical Analyzes  
Between-group comparisons were made using unpaired Student t-test with Bonferroni correction. A p value of <0.05 was 
considered to indicate a significant difference. 
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RESULTS 
Effects of PCA on GS activities in liver, muscle and brain regions are shown in Table 1. 
 
 
Table 1.  Effects of portacaval anastomosis on GS activities in liver, brain and skeletal muscle. 
 
  GS Activity 
  (umole/mg protein/h) 
Tissue Sham-operated PCA 
Liver 1.08±0.08 0.36±0.2** 
Muscle 0.29±0.03 0.45±0.05* 
Brain   
Cerebral Cortex 2.01 ±0.15 1.32±0.10* 
Cerebellum 3.90±0.41 2.81±0.26* 
 
Values represent mean ± S.E. of duplicate determinations from 6 rats per treatment group. Values significantly different 
from sham-operated control indicated by *p<0.05, **p<0.01 by unpaired Student t-test. 
 
GS activities in tissues from sham-operated control rats were in general agreement with previously-published studies 
(Girard and Butterworth, 1992; Girard et al, 1993). PCA resulted in a 67% decrease (p<0.01) in GS activities in liver 
and a significant 52% increase (p<0.05) of enzyme activity in skeletal muscle. A significant loss of GS activity was 
observed in both cerebral cortex and cerebellum of PCA rats. 
Effects of PCA on GS protein in cerebral cortex, cerebellum, muscle and liver are shown in Figure 1 and Table 2. As can 
be seen, there was no significant effect of PCA on GS protein in brain regions or in muscle; in the case of muscle, both 
sham-operated and PCA rat samples showed a wide variation in GS protein. In the case of liver, GS protein was 
severely decreased in PCA rats compared to sham-operated controls (Figure 1); in one case (lane 11) GS protein 
following shunting was below the level of detection. 
 
 
 
 
 
 
 
 
 
 
Figure 1: Effect of portacaval anastomosis (shunt) on GS protein in brain regions, muscle and liver compared to 
sham-operated controls (sham). Note the variability in GS protein in muscle in both experimental groups and the 
severe loss of GS in liver of shunted animals consistent with a loss of GS-rich perivenous hepatocytes. 
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Table 2. Effect of portacaval anastomosis (shunt) on GS protein in liver, brain and skeletal muscle. 
  GS Protein (O.D. units) 
Tissue 
Sham-
operated Shunt 
Liver 0.41±0.01 0.06±0.02* 
Muscle 0.35±0.02 0.36±0.02 
Brain   
Cerebral cortex 0.60±0.04 0.58±0.05 
Cerebellum 0.54±0.01 0.51 ±0.19 
 
Values represent mean ± S.E. of duplicate determinations from 6 rats per treatment group. Values significantly different from 
sham-operated controls indicated by *p<0.05 by unpaired Students t-test. 
 
 
 
Figure 2: Decreased glutamine synthetase (GS) gene expression in the liver of rats following portacaval 
anastomosis. Total RNA was extracted from the liver of animals following portacaval anastomosis (shunt, 
lanes 3-8) or sham operation (sham, lanes 10-15). B-Actin (347 bp) and glutamine synthetase (482 bp) were 
reverse-transcribed and amplified by PCR for 24 cycles. Lane 1: molecular weight standards (bp); lanes 2 and 
8: AMV reverse transcriptase was omitted (as a negative control) from the reaction mixture. 
 
In Figure 2, the effects of PCA on GS mRNA in liver are presented. As was the case with GS protein, GS mRNA in liver of 
PCA rats is severely reduced compared to B-actin (reporter gene). Percent reduction in expression ranged from 50 to 
80% compared to sham-operated control animals. 
DISCUSSION 
Results of the present study reveal tissue-selective alterations of GS expression following portacaval shunting. In the 
case of liver, GS activities were reduced to one third of control values, confirming a previous report (Girard and 
Butterworth, 1992). Reduced liver GS activities undoubtedly result from a selective loss of perivenous hepatocytes 
following PCA. Immunohistochemical studies reveal that GS is preferentially localized in perivenous area of the liver 
lobule (Gerbhardt and Mecke, 1983); perivenous GS removes ammonia which escapes periportal urea synthesis. It has 
been reported that GS activity is reduced by 80% in human cirrhotic liver compared to controls (Kaiser et al., 1988) 
leading to the proposal that the pathogenesis of hyperammonemia in chronic liver disease involves the impairment of 
the perivenous ammonia-scavenging GS-rich hepatocytes. CCl4-induced liver injury also results in loss of perivenous 
hepatocytes and a concomitant loss of GS activity. Results of the present study reveal that PCA, in the absence of 
parenchymal liver cell necrosis, has a similar effect, namely the loss of GS activity as well as GS protein and gene 
expression in the liver. GS is the principal mechanism responsible for ammonia removal by brain under both normal 
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and hyperammonemic conditions (Cooper et al., 1985). GS is localized predominantly in astrocytes (Norenberg and 
Martinez-Hernandez, 1979). Consequently, neurons do not have an effective defense mechanism against increases of 
blood-borne ammonia and must rely on the neighbouring astrocyte for ammonia removal. The vulnerability of neurons to 
increased ammonia is exacerbated by the findings of the present study that GS is not induced in brain in chronic hyperammonemia; 
rather there appears to be a significant loss of GS activity in cerebral cortex and cerebellum of portacaval-shunted rats. Similar 
findings of a lack of induction of GS in brain in hyperammonemic conditions including experimental and human liver failure were 
previously reported (Cooper et al., 1985; Lavoie et al., 1987; Giguere et al., 1989; Butterworth et al., 1988; Qureshi et al., 1995; 
Girard et al., 1993). This lack of induction of brain GS in conditions of chronic liver failure is responsible for the precipitously high 
levels of brain ammonia which may occur in experimental animals with chronic liver failure (Butterworth et al., 1988). 
In addition to resulting in seriously compromised capacity for ammonia removal, a modest loss of GS activity in brain following 
PCA could have serious consequences for glutamatergic synaptic regulation (Butterworth, 1992). Termination of the action of 
synaptically-released glutamate relies almost exclusively on high affinity uptake into the perineuronal astrocyte where it is 
transformed into glutamine via the action of GS. It is interesting therefore that, in studies using astrocytes cultured from different 
brain regions in the rat, high affinity glutamate uptake capacity was found to be highly correlated with regional GS activities 
(Hansson, 1986). Reductions in brain GS activity, as observed in the present and a previous study (Girard et al., 1993), would 
therefore be expected to result in decreased astrocytic glutamate uptake following PCA. In favour of this possibility, several reports 
describe increases of extracellular brain concentrations of glutamate in the brains of PCA rats (Moroni et al., 1983; Tossman et al., 
1987), a finding which is consistent with diminished astrocytic uptake in the brains of these animals. 
In the case of skeletal muscle, GS activities were significantly increased following portacaval shunting, a finding which confirms a 
previous report (Girard and Butterworth, 1992). GS protein expression showed a wide variability in both sham-operated and PCA 
groups of animals, a finding which may reflect a variable loss of muscle mass in chronic liver failure as a result of nutritional 
factors. Further studies are necessary in order to address this issue. It has been suggested that muscle ammonia uptake is increased 
in chronic liver failure and that the subsequent increase in glutamine synthesis capacity is a major alternative pathway for ammonia 
detoxification (Lockwood et al., 1979; Girard and Butterworth, 1992). Results of the present study confirm this possibility. 
Furthermore, results of the present study suggest that the increased GS activity in skeletal muscle in chronic liver failure is not due 
to induction of GS gene expression in muscle. Rather, the finding of unaltered GS protein and mRNA in muscle following PCA 
suggests that the increased GS activities observed are the result of a post-translational modification of the enzyme. 
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